BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2106109)

  • 1. Unsuspected leiomyosarcoma: treatment with a gonadotropin-releasing hormone analogue.
    Meyer WR; Mayer AR; Diamond MP; Carcangiu ML; Schwartz PE; DeCherney AH
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):529-32. PubMed ID: 2106109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist.
    Lee WY; Tzeng CC; Chou CY
    Gynecol Oncol; 1994 Jan; 52(1):74-9. PubMed ID: 8307505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leiomyosarcoma of the uterus: a clinicopathological report of two cases and review of literature.
    Omoniyi-Esan GO; Badmos KB; Adeyemi AB; Rotimi O
    Afr J Med Med Sci; 2008 Sep; 37(3):285-8. PubMed ID: 18982823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental finding of endolymphatic stromal myosis during luteinizing hormone releasing hormone agonist therapy for suspected benign uterine myomata. A case report.
    Smith S; Cooper M; Schinfeld JS
    J Reprod Med; 1992 Dec; 37(12):980-2. PubMed ID: 1287209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatment.
    Friedman AJ
    Fertil Steril; 1989 Jul; 52(1):152-4. PubMed ID: 2501108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review.
    Milman D; Zalel Y; Biran H; Open M; Caspi B; Hagay Z; Dgani R
    Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):237-40. PubMed ID: 9481582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume.
    Murphy NJ; Wallace DL
    Gynecol Oncol; 1993 May; 49(2):266-7. PubMed ID: 8504999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leiomyosarcoma of uterus--a case report.
    Singh AM; Konjengbam R; Devi SS; Devi NP
    J Indian Med Assoc; 2006 Mar; 104(3):142, 144, 147. PubMed ID: 16910338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
    Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
    Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adenomyosis with long-term GnRH analogues: a case report.
    Grow DR; Filer RB
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):538-9. PubMed ID: 1908069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.
    Nappi L; Di Spiezio Sardo A; Indraccolo U; Bettocchi S
    J Minim Invasive Gynecol; 2008; 15(3):380-3. PubMed ID: 18439518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
    Scheer ML; Slebos DJ; Bogchelman DH; Timens W
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-puerperal inversion of the uterus caused by leiomyosarcoma: a case report and clinical management.
    Buyukkurt S; Vardar MA; Zeren H; Ozgunen FT
    J Obstet Gynaecol Res; 2007 Jun; 33(3):402-6. PubMed ID: 17578377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leiomyosarcomas: clinical presentation.
    Schwartz LB; Diamond MP; Schwartz PE
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):180-3. PubMed ID: 8420323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.